3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
6
Pancreatic Neoplasms
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Lymphoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
14
Nivolumab
6
Carboplatin
5
sargramostim
4
Fluorouracil
4
Drug Therapy
4
Thiotepa
3
Sorafenib
3
Radiotherapy
3
Ipilimumab
3
Interferon-alpha
3
Gemcitabine
3
Filgrastim
3
Counseling
3
Cetuximab
3
liposomal doxorubicin
2
ixabepilone
2
entinostat
2
cemiplimab
2
belinostat
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Sirolimus
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Paclitaxel
2
Methods
2
Melphalan
2
Irinotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Referral and Consultation
×
Gastrointestinal
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts